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Coenzyme A functions as a carrier of acetyl and acyl
groups in living cells and is essential for numerous bio-
synthetic, energy-yielding, and degradative metabolic
pathways. There are five enzymatic steps in CoA biosyn-
thesis. To date, molecular cloning of enzymes involved
in the CoA biosynthetic pathway in mammals has been
only reported for pantothenate kinase. In this study, we
present cDNA cloning and functional characterization
of CoA synthase. It has an open reading frame of 563 aa
and encodes a protein of 60 kDa. Sequence alignments
suggested that the protein possesses both phospho-
pantetheine adenylyltransferase and dephospho-CoA
kinase domains. Biochemical assays using wild type re-
combinant protein confirmed the gene product indeed
contained both these enzymatic activities. The presence
of intrinsic phosphopantetheine adenylyltransferase ac-
tivity was further confirmed by site-directed mutagene-
sis. Therefore, this study describes the first cloning and
characterization of a mammalian CoA synthase and con-
firms this is a bifunctional enzyme containing the last
two components of CoA biosynthesis.
Coenzyme A (CoA)1 is the principal acyl and acetyl group
carrier in cells and participates in the metabolism of fatty
acids, carbohydrates, and amino acids (1–3). CoA is also in-
volved in the regulation of several key reactions in intermedi-
ary metabolism. It is estimated that about 4% of all cellular
enzymes utilize CoA or its thioester derivatives as substrates.
The biosynthesis of CoA in mammalian cells occurs in five
steps, which utilize pantothenate (vitamin B5), ATP, and cys-
teine (4). In the first step, pantothenic acid is phosphorylated to
4-phosphopantothenic acid in a reaction mediated by panto-
thenate kinase. This is a rate-limiting step in CoA biosynthesis,
and the activity of pantothenate kinase is strongly inhibited by
coenzyme A and all of its acyl esters (5–7). The product of the
first reaction is then converted to 4-phosphopantothenoylcys-
teine, which is subsequently decarboxylated to 4-phosphopanto-
theine. The 4-phosphopantothenoylcysteine synthase and phos-
phopantothenoylcysteine decarboxylase catalyze these two
reactions, respectively. Another rate-limiting step in this biosyn-
thetic pathway involves the conversion of 4-PP to dPCoA by
4-phosphopantotheine adenylyltransferase. Dephospho-CoA ki-
nase phosphorylates the 3-hydroxyl group of the ribose ring of
dPCoA in the final stage of CoA biosynthesis.
The tissue level of CoA is regulated by various extracellular
stimuli, including hormones, nutrients, and cellular metabo-
lites. It has been shown that insulin, glucose, fatty acids, pyru-
vate, and ketone bodies inhibit CoA biosynthesis, while glu-
cocorticoids and glucagon, as well as drugs such as clofibrate,
increase tissue concentration of CoA (8–12). Altered homeosta-
sis of CoA has been observed in diverse disease states, such as
diabetes, starvation, alcoholism, Reye syndrome, medium-
chain acyl CoA dehydrogenase deficiency, vitamin B12 defi-
ciency, hypertension, and certain types of tumors (13–19).
Enzymatic activities responsible for each step of CoA biosyn-
thesis have been purified from various mammalian sources and
characterized. However, these studies have not been extended
into protein sequence analysis and cDNA cloning of enzymes
involved in the pathway of CoA biogenesis. Recently, bioinfor-
matic studies led to the identification and characterization of a
gene and a cDNA coding for mammalian pantothenate kinase
(20, 21). Here, we report molecular cloning of CoA synthase,
which encodes a protein of 563 amino acids. Sequence align-
ments, mutational analysis, and biochemical characterization
indicated that CoAsy possesses two enzymatic domains, which
mediate the last two steps in CoA biosynthesis: conversion of
4-PP into dPCoA and subsequently into CoA.
EXPERIMENTAL PROCEDURES
Cell Cultures and Antibodies—HEK293 cell line was purchased from
the American Type Culture Collection and maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf serum and
antibiotics. Anti-Myc (9E-10) monoclonal antibody was purchased from
Santa Cruz. A His-tag fusion protein, containing the C-terminal domain
of CoAsy (His-dCoAK) was used to raise specific polyclonal antibodies.
Immunoreactive sera were affinity-purified on an Actigel matrix con-
taining His-dPCoAK fusion protein.
Yeast Two-hybrid Screen—The DupLEX-A yeast two-hybrid system
was used in this study (OriGENE Technologies). The pEG202/S6K
“bait” construct was created by standard cloning techniques and used to
screen a mouse embryo cDNA library. Autoactivation assay, testing for
nuclear localization of the bait fusion protein, selection of positive
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clones, and mating assay were performed as recommended by the
manufacturer.
Northern and Western Blot Analysis—A mouse tissue mRNA blot (a
generous gift from Dr. V. Buchman) was hybridized with an 850-bp
cDNA fragment of CoAsy. The probe was labeled using the Readip-
rimeTMII random prime labeling kit from Amersham Biosciences.
Chicken -actin cDNA probe was used as a control.
Homogenates of adult rat tissues and cell lines were prepared in lysis
buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton
X-100, 50 mM NaF, 1 mM EDTA, and a mixture of protease inhibitors
(Roche Molecular Diagnostics). A portion of total lysate (40 g) from
each tissue and cell line was separated by SDS-PAGE and immuno-
blotted with affinity-purified anti-CoAsy antibodies.
Plasmid Construction and Expression Studies—Full-length CoAsy
was amplified by PCR and cloned into pcDNA3.1 vector (Invitrogen) in
frame with the N-terminal Myc-tag epitope. The dPCoAK domain was
cloned into pET23d plasmid (Novagene) in-frame with His-tag se-
quences, located at the N terminus. Expression and affinity purification
of His-dPCoAK was carried out in BL21 DE3 cells and on NTA-agarose,
respectively. Transient transfection of HEK293 cells was performed
using Polyfect under conditions recommended by the manufacturer
(Qiagen). Immunoprecipitation assays and Western blot analysis were
carried out as described previously (22).
QuikChange site-directed mutagenesis kit (Stratagene) was used to
generate a point mutation in the PPAT domain (His203 to Ala). All
constructs were verified by DNA sequencing.
Analysis of CoA Synthase Activities—The PPAT activity of CoAsy
was measured as described below. The immunoprecipitates, containing
Myc-CoAsy were mixed with 0.2 mM 4-PP, 0.25 mM ATP, 0.5 Ci of
[-32P]ATP, in BB1 buffer (50 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 1.5
mM DTT). The reaction mixture was incubated at 25 °C for 30 min.
Reaction products were separated by descending paper chromatogra-
phy using Whatman 3MM paper and developing system containing
isobutyric acid:0.5 N ammonium hydroxide (100:60) and 1 mM EDTA
(23). A phosphoimager system (Bio-Rad) was used to identify the posi-
tion of radiolabelled products.
Dephospho-CoA kinase activity of immune complexes or recombinant
His-dPCoAK was assayed at 25 °C for 30 min in buffer containing 150
mM Tris-HCl, pH 8.0, 10 mM MgCl2, 1.5 mM DTT, 0.2 mM dPCoA, 0.25
mM ATP, 0.5 Ci of [-32P]ATP. The reaction products were separated
and analyzed in the same way as described above for the PPAT assay.
Both PPAT and dPCoAK activities were also measured spectropho-
tometrically using enzymatic systems as described previously (24).
RESULTS
Using the full-length coding sequence of ribosomal S6 kinase
II (S6KII) as bait in a yeast two-hybrid screen of a mouse
embryo cDNA library, we isolated 16 positive clones, which
were confirmed by mating assay. Restriction analysis and DNA
sequencing revealed that 13 clones contained the same insert.
One of these cDNA clones, designated Ukr1, was fully se-
quenced and found to have an open reading frame that trans-
lated into a protein of 563 amino acids (Fig. 1). The deduced
amino acid sequence has a calculated molecular weight of
62,023. Sequence alignments indicated that the central region
of Ukr1 shows high homology to phosphopantetheine adenylyl-
FIG. 1. Multiple sequence alignments and domain structure of Ukr1. A, alignment of the predicted amino acid sequence of Ukr1 with
homologous sequences derived from H. sapiens, D. melanogaster, A. thaliana, and S. cerevisiae. Sequences were aligned using ClustalW. The data
base sequence numbers are as follows: H. sapiens (GenBankTM accession number AF453478), D. melanogaster (GenBankTM accession number
AAF50749), C. elegans (GenBankTM accession number AAK29952), A. thaliana (GenBankTM accession numbers AAD15511 and AAD15601) and
S. cerevisiae (GenBankTM accession numbers NP011793 and NP010482). Identical amino acids are shown on dark background, while conserved
amino acids are framed. B, domain organization of Ukr1/CoA synthase and its homologues from various organisms. In C. elegans, A. thaliana, S.
cerevisiae, and prokaryotes PPAT and dPCoAK domains reside on different proteins. The hydrophobic insert in C. elegans dPCoAK domain is
shown as a white box. The N-terminal extension is only present in eukaryotes.
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transferases, which belong to the superfamily of cytidylyltrans-
ferases (Supplementary data, Fig. 1A). The C-terminal region
is highly homologous to the catalytic domain of dephospho-CoA
kinases (Supplementary data, Fig. 1B). The N terminus of
Ukr1 does not exhibit signatures of any known domains or
motifs. The presence of PPAT and dPCoAK domains strongly
indicated that Ukr1 cDNA might encode a protein involved in
the biosynthesis of CoA. This was an interesting observation,
as there is a previous report describing purification of an en-
zyme from pig liver possessing both PPAT and dPCoAK activ-
ities (25). This bi-functional enzyme with a molecular mass of
57 kDa was termed CoA synthase, as it had the potential to
mediate the final stages of CoA biosynthesis. As the protein
was never sequenced and the gene was not identified, the
hypothesis of a bifunctional CoA synthase was never formally
proven. Based on the observation that Ukr1 contained domains
predicted to have both PPAT and dPCoAK activities combined
with the fact that the Ukr1 gene product has a predicted
molecular mass of 62 kDa, we hypothesized that Ukr1 cDNA
encoded CoA synthase.
Bioinformatic analysis revealed that homologues of mouse
Ukr1/CoAsy are present in Homo sapiens, Drosophila melano-
gaster, Caenorhabditis elegans, Arabidopsis thaliana, and Sac-
charomyces cerevisiae and exhibit 87, 33, 28, 29, and 23%
homology at the protein level, respectively (Fig. 1A). To our
knowledge, none of the gene products of these data base entries
have been biochemically characterized nor shown to possess
PPAT and/or dPCoAK activities. It is important to note that in
prokaryotes and lower eukaryotes PPAT and dPCoAK activi-
ties reside on different proteins (Fig. 1B). The merger of both
enzymatic activities in higher eukaryotes suggests the exist-
ence of a novel, more recently evolved mechanism in the regu-
lation of CoA biosynthesis. Moreover, the N-terminal extension
is only present in eukaryotes and might contain some regula-
tory sequences. Interestingly, the C. elegans homologue con-
tains a highly hydrophobic insert in the middle of dPCoAK
domain and a hydrophobic C-terminal extension.
The expression level of CoAsy in tissues and cell lines was
examined by Northern and Western blot analysis. Probing of
total RNA from mouse tissues with a radioactively labeled
fragment of CoAsy revealed a major transcript of 2.3 kb and
two minor bands at around 1.7 and 2 kb (Fig. 2A). The highest
expression levels were found in kidney and liver, whereas
colon, lung, intestine, and spleen showed the lowest levels of
transcripts. The probe of chicken -actin cDNA was used as a
control (Fig 2A, lower panel).
To analyze expression of CoAsy at the protein level, the
C-terminal region of CoAsy containing the dPCoAK domain
was expressed in bacteria as His-tag fusion protein (His-
dPCoAK). Recombinant protein was purified by affinity chro-
matography on NTA-agarose and used to generate polyclonal
antibodies. Affinity-purified antibodies specifically recognized
His-dPCoAK and the full-length Myc-CoAsy in Western blot-
ting and immunoprecipitation experiments (Supplementary
data, Fig. 2). When rat tissue lysates were immunoblotted with
anti-CoAsy antibody, a major immunoreactive band was ob-
served at around 60 kDa, which was slightly lower than recom-
binant Myc-CoAsy expressed in HEK293 cells. CoAsy expres-
sion is high in kidney, liver, and brain, whereas ovaries and
lung express low levels of the protein (Fig. 2B). There is a good
correlation between CoAsy tissue expression patterns at the
RNA and protein levels. Immunoblotting also revealed that
CoAsy was present in a wide range of cell lines including
3T3-L1 adipocytes and J774.4 macrophages (Fig. 2C). There-
fore we conclude that CoAsy is a widely distributed enzyme,
but particularly significant levels of expression are observed in
tissues exhibiting elevated lipid metabolism such as heart,
liver, and fat.
To determine whether the CoAsy cDNA encodes a protein
possessing the predicted enzymatic activities, Myc-tagged
CoAsy was expressed in HEK293 cells and recombinant protein
immunoprecipitated with anti-Myc antibody. Immune com-
plexes were divided and assayed for PPAT and dPCoAK activ-
ities as described under “Experimental Procedures.” When
dPCoA was used as a substrate, the appearance of radioac-
tively labeled CoA was detected by descending paper chroma-
tography (Fig. 3A). Bacterial preparations of His-dPCoAK do-
main were also tested in this assay and found to possess
dPCoAK activity (Fig. 3A). To test the presence of PPAT activ-
FIG. 2. Expression of CoAsy in cell lines and tissues. A, North-
ern blot analysis of CoAsy expression in mouse tissues. Details of the
specific probes and blotting conditions are described under “Experimen-
tal Procedures.” The blot was stripped and reprobed for -actin expres-
sion (lower panel). Immunoblot analysis of CoAsy expression in rat
tissues (B) and various cell lines (C). The antigen-antibody complexes
were detected using enhanced chemiluminescence and fluoroimaging
system (Bio-Rad).
FIG. 3. CoA synthase mediates the last two steps in CoA bio-
synthesis. A, Analysis of PPAT and dPCoAK activities of CoAsy. Af-
finity-purified His-dPCoAK (0.5 g) or immune complexes containing
Myc-CoAsy expressed in HEK293 cells were assayed for PPAT and
dPCoAK activities as described under “Experimental Procedures.” B,
schematic presentation of the CoA biosynthetic pathway.
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ity, immunoprecipitated Myc-CoAsy was incubated in a reac-
tion mixture containing 4-PP as the substrate. To convert
4-PP to CoA, both the PPAT and dPCoAK activities are re-
quired (Fig. 3B). The production of radiolabeled CoA in this
assay (Fig. 3A) confirmed that CoAsy does indeed possess both
activities. Commercial preparations of cold CoA and 4-PP were
used as standards. Furthermore, PPAT and dPCoAK activities
of CoAsy were also confirmed using enzymatic systems and
spectrophotometric analysis as described under “Experimental
Procedures” (data not shown).
The crystal structure of bacterial PPAT in complex with
4-PP has been determined recently (26). The structure allowed
the identification of amino acid residues, which are essential
for substrate recognition and catalytic activity. Based on these
structural studies and mutational analysis of critical amino
acid residues in the catalytic pocket of cytidylyltransferases
(27), we mutated His203 to alanine in the PPAT domain of
CoAsy. Transient expression studies in HEK293 cells followed
by immunoprecipitation and an in vitro PPAT assay unambig-
uously demonstrated that the Myc-CoAsy-H203A mutant is not
capable of generating CoA when 4-PP is used as a substrate
(Fig. 3A). At the same time, dPCoAK activity of the Myc-CoAsy-
H203A mutant remains unaltered.
Therefore, based on sequence alignments and biochemical
characterization, we can conclude that the Ukr1 cDNA encodes
the missing link in CoA biosynthesis, the bifunctional enzyme
CoA synthase (Fig. 3B). Since CoAsy was identified in a yeast
two-hybrid screen as an S6K-binding partner, we are currently
investigating the specificity of this interaction in mammalian
cells and its functional consequences.
DISCUSSION
Vitamin B5 is a key component in the biosynthesis of CoA. It
is readily available from diverse dietary sources, a fact that is
underscored by the difficulty encountered in attempting to
induce pantothenate deficiency. Vitamin B5 deficiency has not
been linked with any particular disease, but results in gener-
alized malaise clinically. It has been demonstrated that tissue
CoA levels are not significantly altered in pantothenate defi-
ciency, suggesting that cells are equipped to preserve their
pantothenate content, possibly by a recycling mechanism for
utilizing pantothenate obtained from the degradation of pan-
tothenate-containing molecules.
Biosynthesis of CoA is a universal pathway, conserved from
prokaryotes to mammals. Multistep biosynthesis of CoA and
the enzymes involved in this process are shown in Fig. 3B. This
study reports the molecular cloning and biochemical character-
ization of mammalian CoA synthase, previously a gap in the
genetics of the mammalian CoA biosynthetic pathway. The
presence of PPAT and dPCoAK domains in the predicted amino
acid sequence of murine CoAsy strongly suggested its involve-
ment in the biosynthesis of CoA. Expression studies in HEK293
cells provided evidence that recombinant CoAsy possesses both
PPAT and dPCoAK activities. These findings were further sup-
ported by mutational studies and biochemical analysis of bac-
terially expressed dPCoAK domain. Interestingly, D. melano-
gaster and C. elegans have homologues of mammalian CoAsy,
while in lower eukaryotes, such as S. cerevisiae and bacteria,
the PPAT and dPCoAK activities reside on different proteins.
These differences suggest the existence of distinct modes of
regulation of CoA biosynthesis. Indeed, the CoA-synthesizing
complex in S. cerevisiae was found to have a molecular mass
around 400 kDa, while in higher eukaryotes, the existence of
such a complex has not been reported (23). The compartmen-
talization of the CoA biosynthetic pathway is poorly understood
in mammals. Since mitochondria and peroxisomes contain the
greatest concentrations of CoA, it has been proposed that the
last enzymes in the pathway are located inside these compart-
ments (28). Others report that mitochondria can transport CoA
into the matrix, implying that all CoA synthesizing enzymes
are cytosolic proteins (29). Analysis of subcellular localization
of CoAsy supports the latter hypothesis, as CoAsy is located
predominately in the cytoplasm.2
Metabolic labeling experiments have revealed that both pan-
tothenate and 4-PP accumulate in the cell, suggesting that
pantothenate kinase and PPAT catalyze rate-limiting steps in
the pathway (30). Therefore, it is apparent that the PPAT
activity of CoAsy might be regulated in cellular responses to
extracellular stimuli or environmental changes. The availabil-
ity of the molecular reagents that have evolved from this study
will allow us to study regulatory mechanisms governing the
final stages of CoA biosynthesis.
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